에 대한 최신 뉴스 36KR Holdings (NASDAQ:KRKR) 주식

36KR Holdings

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

36Kr Holdings Inc. - American Depositary Shares

36KR Holdings Inc

<p><strong>Atlassian</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEAM#NASDAQ">TEAM</a>) just disclosed its Q2 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Atlassian beat estimated earnings by 26.0%, reporting an EPS of $0.96 versus an estimate of $0.76.</p>
<p>Revenue was up $226.00 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>In the previous quarter, the company beat on EPS by $0.13, resulting in a 19.0% increase change in the share price the following day.</p>
<p>Here's a look at Atlassian's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.64</td>
<td>0.61</td>
<td>0.62</td>
<td>0.62</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.77</td>
<td>0.66</td>
<td>0.89</td>
<td>0.73</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>1.15B</td>
<td>1.13B</td>
<td>1.10B</td>
<td>1.02B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>1.19B</td>
<td>1.13B</td>
<td>1.19B</td>
<td>1.06B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Atlassian <a href="https://www.benzinga.com/quote/TEAM/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings

TEAM

Atlassian Q2 Earnings Assessment

<p><strong>Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBBK#NASDAQ">TBBK</a>) announced its Q4 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Bancorp beat estimated earnings by 2.0%, reporting an EPS of $1.15 versus an estimate of $1.13.</p>
<p>Revenue was up $2.14 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>During the previous quarter, the company missed on EPS by $0.08, leading to a 14.000000000000002% drop share price change the next day.</p>
<p>Here's a look at Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.12</td>
<td>1.07</td>
<td>1.05</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.04</td>
<td>1.07</td>
<td>1.06</td>
<td>0.95</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>99.31M</td>
<td>96.41M</td>
<td>116.51M</td>
<td>90.65M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>93.73M</td>
<td>93.80M</td>
<td>94.42M</td>
<td>92.16M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Bancorp management provided guidance for FY 2025, expecting earnings between $5.25 and $5.25 per share.</p>
<p>To track all earnings releases for Bancorp <a href="https://www.benzinga.com/quote/TBBK/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


TBBK

Bancorp Q4 Earnings Assessment

<p><strong>Standex International</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXI#NYSE">SXI</a>) released its Q2 earnings on Thursday, January 30, 2025 at 04:01 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Standex International beat estimated earnings by 14.000000000000002%, reporting an EPS of $1.91 versus an estimate of $1.67.</p>
<p>Revenue was up $11.41 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>In the previous quarter, the company beat on EPS by $0.01, resulting in a 4.0% increase change in the share price the following day.</p>
<p>Here's a look at Standex International's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.70</td>
<td>1.72</td>
<td>1.67</td>
<td>1.72</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.71</td>
<td>1.76</td>
<td>1.75</td>
<td>1.78</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>181.39M</td>
<td>181.29M</td>
<td>180.14M</td>
<td>182.52M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>170.46M</td>
<td>180.19M</td>
<td>177.27M</td>
<td>178.40M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Standex International <a href="https://www.benzinga.com/quote/SXI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Standex International Earnings Report: Q2 Overview

<p>The Q4 earnings report for <strong>Eastman Chemical</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMN#NYSE">EMN</a>) was released on Thursday, January 30, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Eastman Chemical beat estimated earnings by 19.0%, reporting an EPS of $1.87 versus an estimate of $1.57.</p>
<p>Revenue was up $38.00 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company beat on EPS by $0.12 which was followed by a 4.0% drop in the share price the next day.</p>
<p>Here's a look at Eastman Chemical's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.14</td>
<td>2.01</td>
<td>1.43</td>
<td>1.30</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.26</td>
<td>2.15</td>
<td>1.61</td>
<td>1.31</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>2.38B</td>
<td>2.36B</td>
<td>2.29B</td>
<td>2.21B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>2.46B</td>
<td>2.36B</td>
<td>2.31B</td>
<td>2.21B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Eastman Chemical management provided guidance for FY 2025, expecting earnings between $8.0 and $8.75 per share.</p>
<p>To track all earnings releases for Eastman Chemical <a href="https://www.benzinga.com/quote/EMN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Insights into Eastman Chemical Q4 Earnings

News

Dividends

Walgreens Boots Alliance Suspends Quarterly Dividend

<p>The earnings results for <strong>Arthur J. Gallagher</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) for Q4 were made public on Thursday, January 30, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Arthur J. Gallagher beat estimated earnings by 5.0%, reporting an EPS of $2.13 versus an estimate of $2.03.</p>
<p>Revenue was up $284.00 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>Last quarter the company missed on EPS by $0.01 which was followed by a 2.0% drop in the share price the next day.</p>
<p>Here's a look at Arthur J. Gallagher's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.27</td>
<td>2.24</td>
<td>3.41</td>
<td>1.85</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.26</td>
<td>2.26</td>
<td>3.49</td>
<td>1.85</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>2.78B</td>
<td>2.76B</td>
<td>3.18B</td>
<td>2.36B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>2.81B</td>
<td>2.77B</td>
<td>3.26B</td>
<td>2.43B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Arthur J. Gallagher <a href="https://www.benzinga.com/quote/AJG/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Recap: Arthur J. Gallagher Q4 Earnings

<p>The earnings results for <strong>Adtalem Glb Education</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATGE#NYSE">ATGE</a>) for Q2 were made public on Thursday, January 30, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Adtalem Glb Education beat estimated earnings by 32.0%, reporting an EPS of $1.81 versus an estimate of $1.37.</p>
<p>Revenue was up $54.49 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>The company beat on EPS by $0.16 in the previous quarter, leading to a 10.0% increase share price change the next day.</p>
<p>Here's a look at Adtalem Glb Education's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.13</td>
<td>1.28</td>
<td>1.16</td>
<td>0.98</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.29</td>
<td>1.37</td>
<td>1.50</td>
<td>1.23</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>397.70M</td>
<td>398.63M</td>
<td>391.70M</td>
<td>372.79M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>417.40M</td>
<td>409.91M</td>
<td>412.66M</td>
<td>393.24M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Adtalem Glb Education management provided guidance for FY 2025, expecting earnings between $6.1 and $6.3 per share.</p>
<p>To track all earnings releases for Adtalem Glb Education <a href="https://www.benzinga.com/quote/ATGE/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Adtalem Global Education Inc. Common Stock

ATGE

Insights into Adtalem Glb Education Q2 Earnings

<p><strong>Boot Barn Holdings</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) just disclosed its Q3 earnings on Thursday, January 30, 2025 at 04:10 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Boot Barn Holdings beat estimated earnings by 2.0%, reporting an EPS of $2.43 versus an estimate of $2.38.</p>
<p>Revenue was up $87.77 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>Last quarter the company missed on EPS by $0.0 which was followed by a 20.0% drop in the share price the next day.</p>
<p>Here's a look at Boot Barn Holdings's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.95</td>
<td>1.02</td>
<td>0.88</td>
<td>1.79</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.95</td>
<td>1.26</td>
<td>0.91</td>
<td>1.81</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>423.30M</td>
<td>411.38M</td>
<td>384.89M</td>
<td>521.36M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>425.80M</td>
<td>423.39M</td>
<td>388.46M</td>
<td>520.40M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Boot Barn Holdings management provided guidance for FY 2025, expecting earnings between $5.81 and $5.9 per share.</p>
<p>To track all earnings releases for Boot Barn Holdings <a href="https://www.benzinga.com/quote/BOOT/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BOOT

Boot Barn Holdings Earnings Analysis: Q3 Recap

<p>The earnings results for <strong>Hartford Finl Servs Gr</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>) for Q4 were made public on Thursday, January 30, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Hartford Finl Servs Gr beat estimated earnings by 11.0%, reporting an EPS of $2.94 versus an estimate of $2.64.</p>
<p>Revenue was up $479.00 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>During the previous quarter, the company missed on EPS by $0.01, leading to a 7.000000000000001% drop share price change the next day.</p>
<p>Here's a look at Hartford Finl Servs Gr's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.54</td>
<td>2.24</td>
<td>2.45</td>
<td>2.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.53</td>
<td>2.50</td>
<td>2.34</td>
<td>3.06</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>6.69B</td>
<td>6.57B</td>
<td>6.51B</td>
<td>6.36B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>6.75B</td>
<td>6.49B</td>
<td>6.42B</td>
<td>6.40B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Hartford Finl Servs Gr <a href="https://www.benzinga.com/quote/HIG/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Summary: Hartford Finl Servs Gr Q4

<p><strong>Ameris</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABCB#NYSE">ABCB</a>) just disclosed its Q4 earnings on Thursday, January 30, 2025 at 04:15 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Ameris beat estimated earnings by 16.0%, reporting an EPS of $1.38 versus an estimate of $1.19.</p>
<p>Revenue was up $28.43 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>During the previous quarter, the company beat on EPS by $0.13, leading to a 3.0% drop share price change the next day.</p>
<p>Here's a look at Ameris's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.25</td>
<td>1.14</td>
<td>1.04</td>
<td>1.10</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.38</td>
<td>1.17</td>
<td>1.10</td>
<td>1.07</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>286.86M</td>
<td>272.81M</td>
<td>258.05M</td>
<td>264.66M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>283.77M</td>
<td>300.63M</td>
<td>267.27M</td>
<td>262.35M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Ameris <a href="https://www.benzinga.com/quote/ABCB/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


ABCB

Recap: Ameris Q4 Earnings

<p><strong>Financial Institutions</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FISI#NASDAQ">FISI</a>) just disclosed its Q4 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Financial Institutions missed estimated earnings by -2.0%, reporting an EPS of $0.55 versus an estimate of $0.56.</p>
<p>Revenue was up $1.75 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>During the previous quarter, the company beat on EPS by $0.08, leading to a 4.0% drop share price change the next day.</p>
<p>Here's a look at Financial Institutions's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.76</td>
<td>2.01</td>
<td>0.59</td>
<td>0.71</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.84</td>
<td>1.62</td>
<td>0.11</td>
<td>0.61</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>42.17M</td>
<td>45.09M</td>
<td>39.52M</td>
<td>40.32M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>40.68M</td>
<td>41.19M</td>
<td>40.08M</td>
<td>39.89M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Financial Institutions <a href="https://www.benzinga.com/quote/FISI/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


FISI

Financial Institutions Earnings Report: Q4 Overview

Offerings

ADNT

Adient Reports Pricing Of $795M Of 7.50% Senior Unsecured Notes Due 2033

<p>DA Davidson  analyst Linda Bolton Weiser   maintains 1-800-Flowers.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLWS#NASDAQ">FLWS</a>) with a Neutral and maintains $7.5 price target.</p>


Price Target

Analyst Ratings

FLWS

DA Davidson Maintains Neutral on 1-800-Flowers.com, Maintains $7.5 Price Target

<p><strong>Apple Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) reported first-quarter financial results after the market close on Thursday. Here&#8217;s a look at the key <a href="https://www.benzinga.com/pressreleases/25/01/b43354083/apple-reports-first-quarter-results">metrics from the quarter</a>.</p>
<p><strong>Q1 Earnings:</strong> Apple reported fiscal first-quarter revenue of $124.3 billion, beating analyst&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">estimates</a> of $124.13 billion. The iPhone maker reported first-quarter adjusted earnings of $2.40 per share, beating analyst estimates of $2.36 per share.</p>
<p>Apple has now beat analyst estimates on the top and bottom lines in eight consecutive quarters, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.</p>
<p>Total revenue was up 4% year-over-year, and earnings per share climbed 10% year-over-year. Americas sales totaled $52.65 billion in the quarter, Europe sales came in at $33.86 billion, Greater China sales were $18.51 billion, Japan sales totaled $8.99 billion and the rest of Asia Pacific sales were $10.29 billion.</p>
<p>Products revenue came in at $97.96 billion, up from $96.46 billion year-over-year. Services revenue totaled $26.34 billion, up from $23.12 billion year-over-year. Here's a breakdown of product sales by category:</p>
<ul>
<li><strong>iPhone:</strong>&nbsp;$69.14 billion, versus $69.7 billion last year</li>
<li><strong>Mac:</strong>&nbsp;$8.99 billion, versus $7.78 billion last year</li>
<li><strong>iPad:</strong>&nbsp;$8.09 billion, versus $7.02 billion last year</li>
<li><strong>Wearables, Home and Accessories:</strong>&nbsp;$11.75 billion, versus $11.95 billion last year</li>
</ul>
<p>Apple noted that its active installed base of devices reached a new all-time high across all products and geographic segments.</p>
<p>&#8220;Today Apple is reporting our best quarter ever, with revenue of&nbsp;$124.3 billion, up&nbsp;4 percent&nbsp;from a year ago,&#8221; said <strong>Tim Cook</strong>, CEO of Apple. </p>
<p>&#8220;Through the power of Apple silicon, we&#8217;re unlocking new possibilities for our users with Apple Intelligence, which makes apps and experiences even better and more personal. And we&#8217;re excited that Apple Intelligence will be available in even more languages this April.&#8221;</p>
<p><strong>See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43347509/tesla-stock-analysts-highlight-fsd-robotaxis-new-vehicles-for-growth-elon-has-never-sounded-so-bullish">Tesla Analysts Highlight FSD, Robotaxis, New Vehicles For Growth: &#8216;Elon Has Never Sounded So Bullish&#8217;</a></strong></p>
<p>Apple's board declared a quarterly cash dividend of&nbsp;25 cents&nbsp;per share. The dividend is payable on Feb. 13 to shareholders of record as of Feb. 10.</p>
<p>Apple didn't provide forward guidance in its first-quarter earnings release, but the company typically provides commentary on the conference call on how it generally expects its different product lines to perform moving forward. Apple's call with analysts and investors will start at 5 p.m. ET.</p>
<p><strong>AAPL Price Action:</strong> <a href="http://benzinga.com/quote/aapl">Apple shares</a> were volatile following the release. The stock was down 0.35% after-hours, trading at $236.76 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/01/43348950/wall-street-remains-flat-microsoft-eyes-heaviest-drop-since-late-2022-gold-sets-fresh-records"><strong>Wall Street Remains Flat, Microsoft Eyes Heaviest Drop Since Late 2022, Gold Sets Fresh Records: What&#8217;s Driving Markets Thursday?</strong></a></li>
</ul>
<p><em>Photo: Courtesy of Apple.</em></p>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#x1f534; WATCH LIVE: Apple Q1 2025 Earnings Call &#x7C; $AAPL" width="500" height="281" src="https://www.youtube.com/embed/Opq7zbzPXL4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>


After-Hours Center

Movers

Tech

AAPL

Apple Q1 Earnings: Revenue Beat, EPS Beat, iPhone Sales Slip, Installed Base Climbs To All-Time High — 'Our Best Quarter Ever'

<p>For the first nine months of 2024, Group Health had revenues of $608 million and Adjusted Net Income of $69 million.</p>
<p>Allstate acquired the Group Health business in 2021 as part of the $4.0 billion acquisition of National General.</p>
<p>&nbsp;The sale is expected to generate a financial book gain of about $450 million, increase deployable capital by $0.9 billion but reduce adjusted net income return on equity by 75 basis points after closing, which is expected in 2025.</p>


Asset Sales

Allstate Inks Definitive Deal To Sell Its Group Health Business To Nationwide For $1.25B In Cash

<p><strong>First Business Finl Servs</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FBIZ#NASDAQ">FBIZ</a>) announced its Q4 earnings on Thursday, January 30, 2025 at 04:00 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>First Business Finl Servs beat estimated earnings by 13.0%, reporting an EPS of $1.43 versus an estimate of $1.26.</p>
<p>Revenue was up $4.52 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>The company beat on EPS by $0.05 in the previous quarter, leading to a 4.0% drop share price change the next day.</p>
<p>Here's a look at First Business Finl Servs's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.19</td>
<td>1.09</td>
<td>1.12</td>
<td>1.13</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.24</td>
<td>1.23</td>
<td>1.04</td>
<td>1.15</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>38.77M</td>
<td>37.25M</td>
<td>37.73M</td>
<td>37.47M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>38.07M</td>
<td>37.97M</td>
<td>36.28M</td>
<td>36.63M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for First Business Finl Servs <a href="https://www.benzinga.com/quote/FBIZ/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


FBIZ

Insights into First Business Finl Servs Q4 Earnings

<p><strong>Gen Digital</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>) just disclosed its Q3 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Gen Digital beat estimated earnings by 2.0%, reporting an EPS of $0.56 versus an estimate of $0.55.</p>
<p>Revenue was up $35.00 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company missed on EPS by $0.0 in the previous quarter, leading to a 8.0% increase share price change the next day.</p>
<p>Here's a look at Gen Digital's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.54</td>
<td>0.53</td>
<td>0.52</td>
<td>0.50</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.54</td>
<td>0.53</td>
<td>0.53</td>
<td>0.49</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>969.93M</td>
<td>965.06M</td>
<td>965.02M</td>
<td>956.20M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>974.00M</td>
<td>965.00M</td>
<td>967.00M</td>
<td>951.00M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Gen Digital management provided guidance for Q4 2025, expecting earnings between $0.57 and $0.59 per share.</p>
<p>To track all earnings releases for Gen Digital <a href="https://www.benzinga.com/quote/GEN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Gen Digital Earnings Review: Q3 Summary

<p><strong>Cavco Indus</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVCO#NASDAQ">CVCO</a>) released its Q3 earnings on Thursday, January 30, 2025 at 04:05 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>Cavco Indus beat estimated earnings by 41.0%, reporting an EPS of $6.9 versus an estimate of $4.89.</p>
<p>Revenue was up $75.27 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company beat on EPS by $0.52 in the last quarter, resulting in a 9.0% increase share price change the following day.</p>
<p>Here's a look at Cavco Indus's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q2 2025</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>4.76</td>
<td>4.70</td>
<td>4.51</td>
<td>4.27</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>5.28</td>
<td>4.11</td>
<td>4.03</td>
<td>4.27</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>479.79M</td>
<td>462.32M</td>
<td>470.11M</td>
<td>425.88M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>507.46M</td>
<td>477.60M</td>
<td>420.12M</td>
<td>446.77M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Cavco Indus <a href="https://www.benzinga.com/quote/CVCO/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CVCO

Cavco Indus Q3 Earnings Assessment

<p><strong>Arthur J. Gallagher</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AJG#NYSE">AJG</a>) reported its Q4 earnings results on Thursday, January 30, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>Arthur J. Gallagher beat estimated earnings by 5.0%, reporting an EPS of $2.13 versus an estimate of $2.03.</p>
<p>Revenue was up $284.00 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>During the previous quarter, the company missed on EPS by $0.01, leading to a 2.0% drop share price change the next day.</p>
<p>Here's a look at Arthur J. Gallagher's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.27</td>
<td>2.24</td>
<td>3.41</td>
<td>1.85</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.26</td>
<td>2.26</td>
<td>3.49</td>
<td>1.85</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>2.78B</td>
<td>2.76B</td>
<td>3.18B</td>
<td>2.36B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>2.81B</td>
<td>2.77B</td>
<td>3.26B</td>
<td>2.43B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Arthur J. Gallagher <a href="https://www.benzinga.com/quote/AJG/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Arthur J. Gallagher Earnings Report: Q4 Overview

<p><strong>Adtalem Glb Education</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATGE#NYSE">ATGE</a>) announced its Q2 earnings on Thursday, January 30, 2025 at 04:15 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Adtalem Glb Education beat estimated earnings by 32.0%, reporting an EPS of $1.81 versus an estimate of $1.37.</p>
<p>Revenue was up $54.49 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous quarter, the company beat on EPS by $0.16, resulting in a 10.0% increase change in the share price the following day.</p>
<p>Here's a look at Adtalem Glb Education's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q1 2025</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.13</td>
<td>1.28</td>
<td>1.16</td>
<td>0.98</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.29</td>
<td>1.37</td>
<td>1.50</td>
<td>1.23</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>397.70M</td>
<td>398.63M</td>
<td>391.70M</td>
<td>372.79M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>417.40M</td>
<td>409.91M</td>
<td>412.66M</td>
<td>393.24M</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Adtalem Glb Education management provided guidance for FY 2025, expecting earnings between $6.1 and $6.3 per share.</p>
<p>To track all earnings releases for Adtalem Glb Education <a href="https://www.benzinga.com/quote/ATGE/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Adtalem Glb Education Q2 Earnings Assessment

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>It&rsquo;s time to dive into the biggest pre-market stock movers as we check out all of the hottest news on Monday morning!</p>



<p>Moving stocks today are a new patent, new agreements, delisting news, a proposed public offering and more.</p>



<p>Let&rsquo;s get into that news below!</p>



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li><strong>Agrify </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/agfy-stock-quote/"><strong>AGFY</strong></a>) stock is rocketing more than 56% alongside heavy pre-market trading.</li>



<li><strong>Sunrise New Energy</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/epow-stock-quote/"><strong>EPOW</strong></a>) shares are soaring over 36% after being <a href="https://www.nasdaq.com/press-release/sunrise-new-energys-lithium-ion-battery-patent-granted-key-funding-guizhou-province">granted a new battery patent funding</a>.</li>



<li><strong>GRI Bio </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/gri-stock-quote/"><strong>GRI</strong></a>) stock is surging close to 32% without any clear news this morning.</li>



<li><strong>Roadzen </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/rdzn-stock-quote/"><strong>RDZN</strong></a>) shares are gaining more than 27% with heavy early morning trading today.</li>



<li><strong>MicroAlgo </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/"><strong>MLGO</strong></a>) stock is increasing over 23% despite a lack of news this morning.</li>



<li><strong>Delta Apparel</strong> (NYSEMKT:<a href="https://investorplace.com/stock-quotes/dla-stock-quote/"><strong>DLA</strong></a>) shares are heading more than 19% higher on Monday morning.</li>



<li><strong>Unusual Machines</strong> (NYSEMKT:<a href="https://investorplace.com/stock-quotes/umac-stock-quote/"><strong>UMAC</strong></a>) stock is rising 19% <a href="https://www.nasdaq.com/press-release/correction-source-unusual-machines-selected-provide-first-drone-red-cats-fangtm-line">on a drone agreement</a>.</li>



<li><strong>Bitcoin Depot</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/btm-stock-quote/"><strong>BTM</strong></a>) shares are climbing over 15% this morning.</li>



<li><strong>Australian Oilseeds</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/coot-stock-quote/"><strong>COOT</strong></a>) stock is jumping 15% on a <a href="https://www.nasdaq.com/press-release/australian-oilseeds-holdings-limited-announces-launch-new-investment-relationship">new investment relationship</a>.</li>



<li><strong>Denali Capital</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/deca-stock-quote/"><strong>DECA</strong></a>) shares are up more than 14% on Monday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li><strong>BitFuFu </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/fufu-stock-quote/"><strong>FUFU</strong></a>) stock is diving over 27% after a major rally on Friday.</li>



<li><strong>DermTech </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/"><strong>DMTK</strong></a>) shares are tumbling more than 25% ahead of its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318404814&amp;type=PDF&amp;symbol=DMTK&amp;cdn=2f95604b7d0b2db1ef0d52c1cc04ae14&amp;companyName=DermTech+Inc&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-20">delisting later this week</a>.</li>



<li><strong>American Rebel</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/areb-stock-quote/"><strong>AREB</strong></a>) stock is taking a 25% beating <a href="https://www.nasdaq.com/press-release/american-rebel-signs-distribution-agreement-dichello-distributors-state-connecticut">following a Friday rally</a>.</li>



<li><strong>36KR </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/krkr-stock-quote/"><strong>KRKR</strong></a>) shares are retreating over 17% after jumping in the <a href="https://investorplace.com/2024/06/why-is-36kr-krkr-stock-up-17-today/">previous day of trading</a>.</li>



<li><strong>Professional Diversity</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/"><strong>IPDN</strong></a>) stock is sliding more than 17% as it <a href="https://investorplace.com/2024/06/why-is-professional-diversity-network-ipdn-stock-down-22-today/">continues negative movement</a>.</li>



<li><strong>G1 Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/gthx-stock-quote/"><strong>GTHX</strong></a>) shares are falling nearly 17% alongside a <a href="https://www.nasdaq.com/press-release/g1-therapeutics-provides-update-phase-3-preserve-2-trial-patients-receiving">Phase 3 clinical trial update</a>.</li>



<li><strong>Allarity Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/allr-stock-quote/"><strong>ALLR</strong></a>) stock is dropping over 16% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318408657&amp;type=PDF&amp;symbol=ALLR&amp;cdn=2b98061f2188998b482fa6052ee2392c&amp;companyName=Allarity+Therapeutics+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-06-21">shareholder meeting plans</a>.</li>



<li><strong>Spectaire </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/spec-stock-quote/"><strong>SPEC</strong></a>) shares are decreasing more than 14% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318408996&amp;type=PDF&amp;symbol=SPEC&amp;cdn=3890204bdd59982142fb7ff1035bfa7b&amp;companyName=Spectaire+Holdings+Inc.&amp;formType=S-1%2FA&amp;formDescription=%5BAmend%5D+General+form+for+registration+of+securities+under+the+Securities+Act+of+1933&amp;dateFiled=2024-06-21">proposed public offering</a>.</li>



<li><strong>Inuvo </strong>(NYSEMKT:<a href="https://investorplace.com/stock-quotes/inuv-stock-quote/"><strong>INUV</strong></a>) stock is slipping over 14% today.</li>



<li><strong>Molecular Partners</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/moln-stock-quote/"><strong>MOLN</strong></a>) shares close out our pre-market stock movers down more than 13% this morning.</li>
</ol><p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-24th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning!</p>



<p>Moving stocks this morning are earnings reports, insider buying, offerings and more.</p>



<p>Let&rsquo;s get into that news below!</p>



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li><strong>Volcon </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/"><strong>VLCN</strong></a>) stock is rocketing more than 78% alongside heavy pre-market trading.</li>



<li><strong>Senti Biosciences</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/snti-stock-quote/"><strong>SNTI</strong></a>) shares are soaring over 47% with strong early morning trading.</li>



<li><strong>GlycoMimetics </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/glyc-stock-quote/"><strong>GLYC</strong></a>) stock is surging more than 39% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318411360&amp;type=PDF&amp;symbol=GLYC&amp;cdn=8f7645b9da4ce31c36360d7737c007dc&amp;companyName=GlycoMimetics+Inc.&amp;formType=4&amp;formDescription=Statement+of+changes+in+beneficial+ownership+of+securities&amp;dateFiled=2024-06-24">alongside insider buying</a>.</li>



<li><strong>Anew Medical</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/leas-stock-quote/"><strong>LEAS</strong></a>) shares are gaining over 38% without any clear news this morning.</li>



<li><strong>Nukkleus </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/nukk-stock-quote/"><strong>NUKK</strong></a>) shares are increasing more than 24% with strong pre-market trading.</li>



<li><strong>Regis </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/rgs-stock-quote/"><strong>RGS</strong></a>) stock is rising over 21% after announcing a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318412499&amp;type=PDF&amp;symbol=RGS&amp;cdn=4f01bbb678bba4ddafaac79f77ec0544&amp;companyName=Regis+Corporation&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-25">senior secured credit facility</a>.</li>



<li><strong>Netcapital</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/ncpl-stock-quote/"><strong>NCPL</strong></a>) shares are heading close to 20% higher with heavy pre-market trading today.</li>



<li><strong>Kaival Brands Innovations</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/"><strong>KAVL</strong></a>) stock is jumping more than 17% <a href="https://www.nasdaq.com/press-release/kaival-brands-announces-closing-60-million-public-offering-2024-06-24">after closing a public offering</a>.</li>



<li><strong>BioXcel Therapeutics</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/btai-stock-quote/"><strong>BTAI</strong></a>) shares are climbing over 13% on <a href="https://www.nasdaq.com/press-release/bioxcel-therapeutics-announces-positive-topline-results-post-marketing-requirement">topline results from a study</a>.</li>



<li><strong>Captivision </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/capt-stock-quote/"><strong>CAPT</strong></a>) stock is up more than 12% on Tuesday morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li><strong>Faraday Future</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/ffie-stock-quote/"><strong>FFIE</strong></a>) stock is plummeting over 25% on plans for a <a href="https://finance.yahoo.com/news/faraday-future-announces-plans-regaining-215900667.html">reverse stock split</a>.</li>



<li><strong>Concord Medical Services</strong> (NYSE:<a href="https://investorplace.com/stock-quotes/ccm-stock-quote/"><strong>CCM</strong></a>) shares are diving more than 22% after a massive rally yesterday.</li>



<li><strong>Beyond Air</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/xair-stock-quote/"><strong>XAIR</strong></a>) stock is tumbling over 19% on <a href="https://finance.yahoo.com/news/beyond-air-inc-xair-reports-212503389.html">lackluster Q4 earnings</a>.</li>



<li><strong>MicroAlgo </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/"><strong>MLGO</strong></a>) shares are retreating more than 19% <a href="https://investorplace.com/2024/06/why-is-microalgo-mlgo-stock-up-113-today/">after rallying yesterday</a>.</li>



<li><strong>SolarEdge Technologies</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/sedg-stock-quote/"><strong>SEDG</strong></a>) stock is taking an over 16% beating on a <a href="https://www.nasdaq.com/press-release/solaredge-technologies-inc-announces-proposed-private-offering-300-million">$300 million private offering</a>.</li>



<li><strong>IGC Pharma</strong> (NYSEMKT:<a href="https://investorplace.com/stock-quotes/igc-stock-quote/"><strong>IGC</strong></a>) shares are dropping more than 16% on its <a href="https://www.nasdaq.com/press-release/igc-reports-financial-results-fiscal-year-ended-march-31-2024-2024-06-24">latest earnings report</a>.</li>



<li><strong>Oragenics </strong>(NYSEMKT:<a href="https://investorplace.com/stock-quotes/ogen-stock-quote/"><strong>OGEN</strong></a>) stock is falling over 15% on a <a href="https://www.stocktitan.net/news/OGEN/oragenics-inc-announces-proposed-public-688vwqnwez4o.html">proposed public offering</a>.</li>



<li><strong>DermTech </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/dmtk-stock-quote/"><strong>DMTK</strong></a>) shares are decreasing nearly 12% after a <a href="https://www.nasdaq.com/press-release/dermtech-files-voluntary-chapter-11-protection-2024-06-18">recent bankruptcy filing</a>.</li>



<li><strong>Professional Diversity</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/ipdn-stock-quote/"><strong>IPDN</strong></a>) stock is slipping more than 11% with recent weakness.</li>



<li><strong>36KR </strong>(NASDAQ:<a href="https://investorplace.com/stock-quotes/krkr-stock-quote/"><strong>KRKR</strong></a>) shares close out our pre-market stock movers down over 10%.</li>
</ol><p><em>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	<p>The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-june-25th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

36Kr partners with Zhi-Tech Group to expand business

36Kr Holdings Inc (KRKR) has released an update. 36Kr Holdings Inc. has announced a significant shift in its management team, with Ms. Lin Wei step...

36Kr Holdings Inc. Appoints New CFO

36Kr Holdings GAAP EPADS of -$0.31, revenue of $14.09M

36Kr Holdings Inc (KRKR) has released an update. 36Kr Holdings Inc., a leading New Economy platform in China, has reported a 9.2% increase in its f...

36Kr Holdings Inc. Navigates Economic Challenges

36Kr Holdings Inc. (KRKR) Q2 2024 Earnings Call Transcript

36Kr Holdings Inc (KRKR) has released an update. 36Kr Holdings Inc., a key player in China's New Economy sector, has announced a plan to modify its...

36Kr Holdings Inc. Announces ADS Ratio Change

36Kr Holdings Inc (KRKR) has released an update. 36Kr Holdings Inc. has successfully regained compliance with Nasdaq's minimum bid price rule after...

36Kr Holdings Inc. Secures Nasdaq Compliance

36Kr Holdings (KRKR) announced that it has recently teamed up with Soften Corporation to launch a news hub, the "36Kr Market Watch" WeChat mini pro...

36Kr Holdings partners with Soften Corporation to launch a news hub

AGFY

ALLR

AREB

BTAI

CAPT

COOT

DECA

DMTK

EPOW

FFIE

FUFU

GLYC

GTHX

INUV

IPDN

KAVL

KRKR

LEAS

MLGO

MOLN

NCPL

NUKK

OGEN

RDZN

SEDG

SNTI

SPEC

UMAC

VLCN

XAIR

Press Releases

36Kr Holdings Inc. Files 2023 Annual Report on Form 20-F

36Kr Hosts "AI Partner • Advanced Productivity" Conference

Contracts

36Kr Enters into Strategic Partnership with SenseTime to Pioneer AGI Innovation

Virtual Production Market Set for Significant Expansion Driven by Technological Innovations & Shifts in Media Consumption Habits

36Kr Partners with Consumer Tech Expert Zhi-Tech Group to Drive Business Expansion

Management

36Kr Holdings Inc. Announces Changes to Management and Board of Directors

36Kr Holdings Inc. to Report 2024 First Half Financial Results on Tuesday, September 3, 2024

36Kr Holdings Inc. Reports Unaudited Financial Results for the First Half of 2024

General

36Kr Further Expands Global Reach, Bringing Awareness of China's Economy Worldwide

36Kr and Soften Partner to Launch Innovative News Hub

FOXA

GROM

Angi

The Arena Group Holdings, Inc. Common Stock

Arena Group Holdings

Bumble

BuzzFeed

Cars.com

DHI Group

EverQuote

Getty Images Holdings, Inc. Class A Common Stock

Getty Images Holdings

IZEA Worldwide

Nextdoor Holdings, Inc. Class A Common Stock

Nextdoor Holdings

MediaAlpha

MoneyHero Limited - Class A Ordinary Shares

MoneyHero

Outbrain

PSQ Holdings

System1

Shutterstock

So-Young International Inc. - American Depository Shares

So-Young Intl

TrueCar

trivago N.V. - American Depositary Shares

trivago

Travelzoo

Vimeo

Vtex

Yalla Group Limited American Depositary Shares, each representing one Class A Ordinary Share

Yalla Group

Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares

Comments

36KR Holdings

뉴스

에 대한 최신 뉴스 36KR Holdings (NASDAQ:KRKR) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌